Management of Patients With Glucocorticoid-Related Diseases and COVID-19

Management of Patients With Glucocorticoid-Related Diseases and COVID-19

The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global health crisis affecting millions of people worldwide. SARS-CoV-2 enters the host cells by binding to angiotensin-converting enzyme 2 (ACE2) after bein...

Full description

Bibliographic Details
Main Authors: Irina Chifu, Mario Detomas, Ulrich Dischinger, Otilia Kimpel, Felix Megerle, Stefanie Hahner, Martin Fassnacht, Barbara Altieri
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Endocrinology
Subjects:
adrenal insufficiency
cushing’s syndrome
adrenocortical carcinoma
hyperaldosteronism
glucocorticoids
COVID-19
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.705214/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.705214/full

Similar Items